Literature DB >> 17887741

Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.

David Rennison1, Adrian P Neal, Gerta Cami-Kobeci, Mario D Aceto, Fernando Martinez-Bermejo, John W Lewis, Stephen M Husbands.   

Abstract

A new series of ligands has been synthesized where the cinnamoyl group of the 14-cinnamoylamino morphinones has been introduced to the 7alpha-substituent of the 6,14-bridged oripavine series. In vitro the compounds were mostly low efficacy partial agonists or antagonists with some selectivity for the mu opioid receptor, with evidence of micro efficacy in vivo. The similarity in SAR between these 6,14-bridged oripavines and the 14-cinnamoylamino series suggests a similar mode of interaction with the micro opioid receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17887741      PMCID: PMC2597403          DOI: 10.1021/jm070255o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Structural determinants of efficacy for kappa opioid receptors in the orvinol series: 7,7-spiro analogues of buprenorphine.

Authors:  S M Husbands; J W Lewis
Journal:  J Med Chem       Date:  2000-01-27       Impact factor: 7.446

2.  Novel analgesics and molecular rearrangements in the morphine-thebaine group. II. Alcohols derived from 6,14-endo-etheno- and 6,14-endo-ethanotetrahydrothebaine.

Authors:  K W Bentley; D G Hardy; B Meek
Journal:  J Am Chem Soc       Date:  1967-06-21       Impact factor: 15.419

3.  Dependence studies of new compounds in the rhesus monkey, rat, and mouse (1985).

Authors:  M D Aceto; L S Harris; E L May
Journal:  NIDA Res Monogr       Date:  1986

4.  A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.

Authors:  P S Portoghese; D L Larson; L M Sayre; D S Fries; A E Takemori
Journal:  J Med Chem       Date:  1980-03       Impact factor: 7.446

5.  Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ring.

Authors:  David Rennison; Humphrey Moynihan; John R Traynor; John W Lewis; Stephen M Husbands
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

6.  Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.

Authors:  N Zaveri; W E Polgar; C M Olsen; A B Kelson; P Grundt; J W Lewis; L Toll
Journal:  Eur J Pharmacol       Date:  2001-09-28       Impact factor: 4.432

7.  Studies of EN-1639A (naltrexone): a new narcotic antagonist.

Authors:  R B Resnick; J Volavka; A M Freedman; M Thomas
Journal:  Am J Psychiatry       Date:  1974-06       Impact factor: 18.112

8.  Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.

Authors:  S D Comer; T F Burke; J W Lewis; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1992-09       Impact factor: 4.030

9.  Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.

Authors:  J R Traynor; S R Nahorski
Journal:  Mol Pharmacol       Date:  1995-04       Impact factor: 4.436

Review 10.  The orvinols and related opioids--high affinity ligands with diverse efficacy profiles.

Authors:  John W Lewis; Stephen M Husbands
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

View more
  6 in total

1.  Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418.

Authors:  Quan Wen; Gang Yu; Yu-lei Li; Ling-di Yan; Ze-hui Gong
Journal:  Acta Pharmacol Sin       Date:  2011-08-22       Impact factor: 6.150

2.  Opioid receptors and the discriminative stimulus effects of ethanol in squirrel monkeys: Mu and delta opioid receptor mechanisms.

Authors:  Donna M Platt; Kristen M Bano
Journal:  Eur J Pharmacol       Date:  2010-10-15       Impact factor: 4.432

Review 3.  Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.

Authors:  János Marton; Anikó Fekete; Paul Cumming; Sándor Hosztafi; Pál Mikecz; Gjermund Henriksen
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

4.  Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.

Authors:  Yan Zhang; Orgil Elbegdorj; Yunyun Yuan; Irina O Beletskaya; Dana E Selley
Journal:  Bioorg Med Chem Lett       Date:  2013-05-16       Impact factor: 2.823

5.  Remodelling of the natural product fumagillol employing a reaction discovery approach.

Authors:  Bradley R Balthaser; Meghan C Maloney; Aaron B Beeler; John A Porco; John K Snyder
Journal:  Nat Chem       Date:  2011-12       Impact factor: 24.427

6.  Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects.

Authors:  Humphrey A Moynihan; Ian Derrick; Jillian H Broadbear; Benjamin M Greedy; Mario D Aceto; Louis S Harris; Lauren C S Purington; Mark P Thomas; James H Woods; John R Traynor; Stephen M Husbands; John W Lewis
Journal:  J Med Chem       Date:  2012-10-31       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.